Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer
{"title":"预防输血传播传染病措施的国际调查——研究结果2:检测和献血者警惕。","authors":"Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer","doi":"10.1111/vox.70056","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).</p><p><strong>Materials and methods: </strong>Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.</p><p><strong>Results: </strong>Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.</p><p><strong>Conclusion: </strong>All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"802-811"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance.\",\"authors\":\"Galen Conti, Jay Epstein, Silvano Wendel, Claude Tayou Tagny, Antoine Lewin, Divjot Singh Lamba, Lesley Bust, Chancelar Kafere, Jean Stanley, Maria Roussakis, Hany Kamel, Roger Y Dodd, Susan L Stramer\",\"doi\":\"10.1111/vox.70056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).</p><p><strong>Materials and methods: </strong>Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.</p><p><strong>Results: </strong>Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.</p><p><strong>Conclusion: </strong>All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"802-811\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70056\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70056","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
An international survey on measures to prevent transfusion-transmitted infectious diseases-study results 2: Testing and donor vigilance.
Background and objectives: The results of a global survey on blood safety measures to prevent transfusion-transmitted infectious diseases (TTIDs) were analysed, focusing on TTID testing requirements, practices and associated donor actions (vigilance).
Materials and methods: Responses by country/region (C/R) were categorized by World Bank income (WBI) levels: low- and lower middle-income (LLMI), upper middle-income (UMI) and high-income (HI). Consensus responses were used for C/Rs with multiple survey responses. Regions within China and India were analysed separately. Survey questions on TTID testing and donor vigilance were compared across WBI levels.
Results: Responses from 74 C/Rs representing 65 countries and Hong Kong were analysed. All C/Rs reported mandatory human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) screening, with a few exceptions for syphilis. Most testing standards were set by national law, using antibody and/or antigen testing for HIV, HBV and HCV; antibody testing was common for syphilis. Nucleic acid testing (NAT) was less common in LLMI than in UMI and HI C/Rs. Confirmatory testing was reported by almost all (96%) C/Rs, often using the same screening test. All C/Rs provided educational material to donors, and deferred/notified donors based on reactive/positive TTID results. Most C/Rs reported reactive/positive results to a central entity, and 89% withdrew and destroyed in-date units from previous collections.
Conclusion: All reporting C/Rs screened for HIV, HBV and HCV, with most using confirmatory testing. Advanced tests such as NAT were less common in LLMI C/Rs. Donor vigilance was consistent across income groups, with education, notification and deferral for TTID results, and most reporting withdrawal/destruction of previous collections.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.